Active Biotech says Japan grants patent for laquinimod ophthalmic formulation
Active Biotech AB publ announced Japan Patent Office has granted a patent for its laquinimod ophthalmic formulation.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Active Biotech AB publ OMXSTO:ACTI